Histiocytosis, Langerhans-Cell Clinical Trials

7 clinical trials for Histiocytosis, Langerhans-Cell across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents — RECRUITING · PHASE1
• Biomarkers for Diagnostic, Prognostic and of Response to Treatment in Adult Langerhans Cell Histiocytosis — RECRUITING
• Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study — RECRUITING
• Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH) — ACTIVE_NOT_RECRUITING
• Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL — COMPLETED · PHASE2
• Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis — TERMINATED · PHASE2
• Cardiovascular Risk Factors and LCH in Adults — OTHER

Refine this search